Cat. No. | Product name | CAS No. |
DC22011 |
BAA473
BAA473 (BAA-473) is a bile acid analogue that functions as the first small molecule activator of the Pyrin inflammasome, induces secretion of IL18 in LPS-primed PBMCs. |
20231-68-9 |
DC20063 |
BACE1-IN-2
BACE1-IN-2 is a 1,4-Oxazine β-Secretase 1 (BACE1) inhibitor with an IC50 of 22 nM. |
1352416-78-4 |
DC8858 |
Bafilomycin A1(Baf-A1)
Featured
Bafilomycin A1 is a vacuolar H+-ATPase inhibitor with IC50 of 0.44 nM. |
88899-55-2 |
DC20740 |
BAL30072
BAL30072 is a monocyclic beta-lactam antibiotic that shows potent activity against MDR Pseudomonas aeruginosa and Acinetobacter sp. Isolates with MIC90 of 8 and 4 ug/ml. |
941285-15-0 |
DC10994 |
Balamapimod
Balamapimod (MKI-833) is an orally active, reversible Ras/Raf/MEK inhibitor developed for antineoplastic potential.. |
863029-99-6 |
DC7541 |
Balapiravir
Balapiravir (R1626, Ro 4588161) is the prodrug of a nucleoside analogue inhibitor of the hepatitis C virus (HCV) RNA-dependent RNA polymerase (R1479, RG1479). |
690270-29-2 |
DC11516 |
Balovaptan
Featured
Balovaptan (RG7314, RG-7314) is a potent, selective vasopressin-1 receptor antagonist.. |
1228088-30-9 |
DC11057 |
Baloxavir acid
Featured
Baloxavir acid (S-033447) is an anti-influenza compound that potently and selectively inhibits the cap-dependent endonuclease within the polymerase PA subunit of influenza A and B viruses. |
1985605-59-1 |
DC9562 |
Balsalazide
Balsalazide is an anti-inflammatory compound used in the treatment of Inflammatory Bowel Disease. |
80573-04-2 |
DC9869 |
Bamaquimast
Bamaquimast is an inhibitor of proton pump extracted from patent US2005165041, example 138. |
135779-82-7 |
DC10385 |
BAR501
Featured
BAR501 is a potent and selective agonist of GPBAR1 with an EC50 of 1 μM. |
1632118-69-4 |
DC10564 |
BAR 502
Featured
BAR502 is a dual FXR and GPBAR1 agonist with IC50 values of 2 μM and 0.4 μM, respectively. |
1612191-86-2 |
DC20317 |
Barbadin
Barbadin is a small molecule that selectively inhibits the β-arrestin/β2-adaptin interaction (IC50=19.1/15.6 uM for β-arrestin1/2) without effect on the formation of receptor/β-arrestin complexes. |
356568-70-2 |
DC4135 |
Bardoxolone methyl
Featured
Bardoxolone methyl (also known as “RTA 402” and “CDDO-methyl ester”) is an orally-available first-in-class synthetic triterpenoid belonging to the antioxidant inflammation modulator (AIM) class. |
218600-53-4 |
DC8258 |
Baricitinib phosphate
Featured
Baricitinib phosphate(INCB 028050; LY 3009104) is a selective JAK1 and JAK2 inhibitor with IC50 of 5.9 nM and 5.7 nM, ~70 and ~10-fold selective versus JAK3 and Tyk2, no inhibition to c-Met and Chk2,showed potent activity against COVID-19(SARS-COV-2). |
1187595-84-1 |
DC8133 |
Batimastat(BB-94)
Featured
Batimastat was used to study the role of MMP in proteolytic release of EGF in human follicular thyroid carcinoma cell line FTC-133. |
130370-60-4 |
DC23719 |
BAY 1024767
BAY 1024767 (BAY1024767) is a higly potent antagonist of androgen receptor (AR) wild-type (IC50=46 nM) and mutant forms located in the AR ligand-binding domain (LBD). |
1273068-71-5 |
DC9939 |
BAY 1082439
BAY 1082439 is a highly selective and balanced PI3Kα/β inhibitor demonstrated potent activity in tumors with activated PI3Kα and loss-of-function of PTEN. |
1375469-38-7 |
DC20750 |
BAY 1143269
BAY 1143269 is a potent, selective, orally bioavailable inhibitor of MNK1 with enzyme IC50 of 40 nM at 2 mM ATP. |
|
DC10376 |
BAY-1143572
BAY 1143572 is a highly selective, potent and orally available inhibitor of PTEFb/CDK9; inhibits the proliferation of AML cell lines with a median IC50 of 385 nM. |
1414943-88-6 |
DC23386 |
BAY 1238097
BAY 1238097 is a novel BET bromodomain inhibitor with IC50 of 50 nM, inhibits the interaction between BRD4, BRD3 or BRD2 and H4 with IC50 values of 63 nM, 609 nM and 2430 nM in the NanoBRET assay. |
1564268-08-1 |
DC23745 |
BAY-2402234
Featured
BAY 2402234 (BAY2402234) is a novel potent, selective, orally bioavailable DHODH inhibitor with IC50 of 1.2 nM (human full-length DHODH). |
2225819-06-5 |